Stay updated on Retinal Imaging Evaluation in Clinical Trial
Sign up to get notified when there's something new on the Retinal Imaging Evaluation in Clinical Trial page.

Latest updates to the Retinal Imaging Evaluation in Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.2%
- Check16 days agoChange DetectedThe page has undergone significant content changes, with the removal of detailed information regarding Age-Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) criteria, while a new version number has been added.SummaryDifference9%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference3%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference3%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.2%
Stay in the know with updates to Retinal Imaging Evaluation in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Retinal Imaging Evaluation in Clinical Trial page.